Trial Profile
Maintenance Therapy With Rituximab After Autologous Transplantation for Non-Hodgkin's Lymphoma.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 17 Apr 2010 New trial record